raloxifene hydrochloride has been researched along with Albuminuria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Simorre, B | 1 |
| Chabin, M; Gautier, JF; Gourdy, P; Guerci, B; Hadjadj, S; Mauco, G; Ragot, S; Roudaut, N; Zaoui, P | 1 |
1 trial(s) available for raloxifene hydrochloride and Albuminuria
| Article | Year |
|---|---|
Effect of raloxifene -- a selective oestrogen receptor modulator -- on kidney function in post-menopausal women with Type 2 diabetes: results from a randomized, placebo-controlled pilot trial.
Topics: Adult; Aged; Albuminuria; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Double-Blind Method; Female; Humans; Middle Aged; Pilot Projects; Placebos; Postmenopause; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Treatment Outcome | 2007 |
1 other study(ies) available for raloxifene hydrochloride and Albuminuria
| Article | Year |
|---|---|
[41th Congress of EASD (European Association for The Study of Diabetes) 10 to 15 September 2005, Athens, Greece].
Topics: Aged; Albuminuria; Antihypertensive Agents; Bone Density Conservation Agents; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Type 2; Diuretics; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypoglycemic Agents; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Multicenter Studies as Topic; Pioglitazone; Prospective Studies; Raloxifene Hydrochloride; Randomized Controlled Trials as Topic; Risk; Spironolactone; Thiazolidinediones; Time Factors | 2006 |